EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells

Karen Mechleb, Nancy Hourani iD, Maya Fakhry iD, Osama A Alyamani, Rouba Hage-Sleiman, Hicham Younes, Antoine Abou Fayad, Nadia Soudani, Amer Sakr, Nadine Darwiche iD, Georges Nemer iD, Raya Saab iD und 2 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0340295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Karen Mechleb und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Ceramides, Apoptosis, Tumor Suppressor Protein p53, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Research Board, American University of Beirut, Medical Practice Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxic stress in solid tumors triggers growth arrest and apoptosis through p53 activation and stabilization. This environment inactivates p53 and drives the expansion of p53-mutant clones, which accentuate tumor aggressiveness. Ceramide, a signaling sphingolipid, was previously identified as a downstream collaborator with p53 in the stress-induced apoptosis and cell cycle arrest. Among sphingolipids, the balance between pro- and anti-apoptotic products, dictated by the expression and activity of appropriate enzymes, helps determine cell fate in response to hypoxia. The current study aimed to understand the role of ceramide in HCT116 human colon cancer cells response to hypoxia in the presence or absence of p53, and to determine whether the modulation of ceramide metabolism could sensitize the resistant p53-deficient cells to hypoxia-induced cell death. We observed that HCT116 p53-deficient cells were resistant to hypoxic cell death. We explored the role of ceramide in this response by screening for different sphingolipid metabolites through liquid-chromatography-mass spectrometry, and by measuring the expression of key enzymes involved in ceramide biosynthesis and breakdown. We also evaluated the changes in the cellular response to hypoxia associated with introduction of sphingolipid metabolites or with modulating the activity of related sphingolipid-metabolizing enzymes. In hypoxic p53-deficient cells, ceramide was synthesized via the de novo pathway through the action of ceramide synthases and dihydroceramide desaturase (DEGS1) driving the evasion of hypoxia-induced apoptosis. Among the accumulating ceramide species in p53 deficient cells, C24-ceramide was the most abundant and possibly contributing to their resistance. Tipping the sphingolipid balance in favor of pro-apoptotic sphingolipids, through the addition of C6 ceramide or sphingosine, or through the combined pharmacologic inhibition of DEGS1 and sphingosine kinase 1, helped circumvent the cellular resistance to hypoxia-induced apoptosis in cells lacking p53. Therefore, modulating sphingolipid metabolism may be a viable approach in the treatment of solid tumors with hypoxic regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesApoptosisTumor Suppressor Protein p53Colonic NeoplasmsHumansHCT116 CellsCell HypoxiaSphingolipidsOxidoreductasesPhosphotransferases (Alcohol Group Acceptor)

Substanzen

CeramidesTumor Suppressor Protein p53SphingolipidsTP53 protein, humanOxidoreductasesPhosphotransferases (Alcohol Group Acceptor)

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Department of Louvain, Institute of Biomolecular Science and Technology, Faculty of Sciences, Catholic University of Louvain, Louvain, Belgium.
  • Department of Pediatrics and Adolescent Medicine, Center for Infectious Diseases Research, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
  • Department of Toxicology, Toxicology Lab Research and Training Center, Faculty of Health Sciences, American University of Science & Technology (AUST), Beirut, Lebanon.
  • Forensic Toxicology Laboratory, Center of Forensic & Digital Sciences, Abu Dhabi Judicial Department (ADJD), United Arab Emirates.
  • Department of Biology, Faculty of Sciences, Lebanese University, Hadath, Lebanon.

ORCID-Profile: Nancy Hourani, Maya Fakhry, Nadine Darwiche, Georges Nemer, Raya Saab

Förderung

  • University Research Board, American University of Beirut
  • Medical Practice Plan

Zitieren

APA

Mechleb, K., Hourani, N., Fakhry, M., Alyamani, O. A., Hage-Sleiman, R., Younes, H., Fayad, A. A., Soudani, N., Sakr, A., Darwiche, N., Nemer, G., Saab, R., Mrad, M., & Dbaibo, G. (2026). Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells. PLOS One. https://doi.org/10.1371/journal.pone.0340295

Vancouver

Mechleb K, Hourani N, Fakhry M, Alyamani OA, Hage-Sleiman R, Younes H, et al. Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells. PLOS One. 2026. doi:10.1371/journal.pone.0340295

BibTeX
@article{Mechleb2026,
  author = {Mechleb, Karen and Hourani, Nancy and Fakhry, Maya and Alyamani, Osama A and Hage-Sleiman, Rouba and Younes, Hicham and Fayad, Antoine Abou and Soudani, Nadia and Sakr, Amer and Darwiche, Nadine and Nemer, Georges and Saab, Raya and Mrad, Marguerite and Dbaibo, Ghassan},
  title = {Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0340295}
}
Kostenlos starten →